How can AChE affect the action of antagonist (nondepolarizing) neuromuscular blockers?

How can AChE affect the action of antagonist (nondepolarizing) neuromuscular blockers?

• A. AChE can enhance the effect of neuromuscular blockers
• B. AChE can prevent the action of neuromuscular blockers
• C. AChE can overcome low doses of neuromuscular blockers
• D. AChE has no effect on neuromuscular blockers

Answer: (C)

The correct answer highlights that AChE can overcome low doses of neuromuscular blockers. Acetylcholinesterase (AChE) is the enzyme responsible for breaking down acetylcholine (ACh) in the synaptic cleft, which is crucial for proper neuromuscular transmission. Nondepolarizing neuromuscular blockers work by competitively inhibiting ACh from binding to nicotinic receptors on the motor end plate, which prevents muscle contraction. When AChE is active, it reduces the concentration of acetylcholine available at the neuromuscular junction. In a situation where low doses of neuromuscular blockers are present, the breakdown of ACh by AChE can lead to a sufficient amount of ACh being available to compete with the neuromuscular blocker. Therefore, the effect of the blocker can be somewhat surpassed under these conditions, allowing partial restoration of muscle contraction. This interplay highlights the balance between AChE activity and the efficacy of neuromuscular blockers, particularly at low doses. In contrast to this correct answer, other options do not accurately capture this dynamic. For instance, while it might seem plausible that AChE could enhance the effect of neuromuscular

The correct answer highlights that AChE can overcome low doses of neuromuscular blockers. Acetylcholinesterase (AChE) is the enzyme responsible for breaking down acetylcholine (ACh) in the synaptic cleft, which is crucial for proper neuromuscular transmission. Nondepolarizing neuromuscular blockers work by competitively inhibiting ACh from binding to nicotinic receptors on the motor end plate, which prevents muscle contraction.

When AChE is active, it reduces the concentration of acetylcholine available at the neuromuscular junction. In a situation where low doses of neuromuscular blockers are present, the breakdown of ACh by AChE can lead to a sufficient amount of ACh being available to compete with the neuromuscular blocker. Therefore, the effect of the blocker can be somewhat surpassed under these conditions, allowing partial restoration of muscle contraction. This interplay highlights the balance between AChE activity and the efficacy of neuromuscular blockers, particularly at low doses.

In contrast to this correct answer, other options do not accurately capture this dynamic. For instance, while it might seem plausible that AChE could enhance the effect of neuromuscular